Foot & Mouth Disease Vaccines Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Foot & Mouth Disease Vaccines Market Analysis
The Foot and mouth disease vaccines market is expected to register a CAGR of 9.8% over the forecast period.
COVID-19 had a significant impact on the growth of the market during the pandemic period. Supply disruption and shortages of veterinary medicines were observed in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for COVID-19 medicines. Governments took measures to mitigate the supply of medicines. Certain specific and precautionary guidelines were given to veterinary professionals to treat companion animals during the COVID-19 pandemic by the Centers for Disease Control and Prevention in July 2020. Also, the incidence of foot and mouth disease in animals amidst COVID-19 is expected to contribute to the growth of the market. For instance, in April 2021, foot and mouth disease struck Arunachal Pradesh amid COVID-19 infections, affecting semi-wild mithuns across the Central and Eastern landscapes of the frontier North-Eastern State in India. Such circumstances led to the demand for the foot and mouth disease vaccine during the pandemic period. Thus, COVID-19 had a significant impact on the growth of the market.
The prevention and treatment of deadly animal diseases are key market indicators for the vaccine market. Certain factors such as increasing incidences of zoonotic diseases, increasing demand for animal products, and rising R&D activities in animal healthcare cause foot and mouth-related diseases are expected to contribute to the growth of the market during the forecast period. The article titled "Novel Foot and Mouth Disease Vaccine platform: Formulations for safe and DIVA compatible FMB vaccines with improved potency" published in September 2020 mentioned that the foot and mouth disease- LL3B3D vaccine platform, undergoing development in the United States, provides opportunities for safer vaccine production with full compatibility in support of the global foot and mouth disease virus control and eradication initiatives.
Zoonotic diseases are naturally transmitted from animals to humans. Adverse climatic transformations and rapid globalization are the major factors increasing the cases of zoonotic diseases over the past decades. Zoonotic diseases are quite common around the world. According to the scientists of the Centers for Disease Control and Prevention (CDC) in July 2021, over 6 out of every 10 known infectious diseases in humans are spread via animals, moreover, 3 out of every 4 new or emerging infectious diseases are spread from animals. So, it is evident that these diseases are major public health problems worldwide.
Thus, the above-mentioned factors are expected to drive the growth of the market during the forecast period. However, high storage costs for vaccines are expected to hamper the growth of the market over the forecast period.
Foot & Mouth Disease Vaccines Market Trends
This section covers the major market trends shaping the Foot & Mouth Disease Vaccines Market according to our research experts:
Cattle Segment is Expected to Witness Significant Growth Over the Forecast Period
The growth of the cattle segment is mainly attributed to the high population of cattle across the world and the dominance of cattle farming as a major income source for people in many countries. For example, in countries such as China and Mexico where the livestock population is high, the chances of getting an infection would be higher. According to the Food and Agriculture Organization (FAO) in September 2021, India's national cattle herd to reach 306.7 million animals in 2022, increasing by 1.2 million head from the 2021 Italy cattle count.
Additionally, the launch of vaccination programs for cattle by various organizations is also expected to drive the growth of the studied segment. For instance, in August 2020, the Prayagraj animal husbandry launched a massive drive to inoculate the vaccines in cows and other cattle from foot and mouth disease.
The awareness about cattle diseases and zoonosis is currently growing due to the high demand for improved and healthy meat. Hence, these factors are anticipated to have a positive impact on the market in the coming years.
North America is Expected to Dominate the Foot and Mouth Disease Vaccines Market
North American region is among the major contributor to the foot and mouth disease vaccines market, owing to the implementation of animal healthcare benefits across the region. The market is growing rapidly due to the presence of advanced animal healthcare programs coupled with awareness regarding animal health is projected to drive the regional market growth.
Moreover, the rising disease burden in animals is further pushing the need for effective and quick treatment options which is expected to propel the growth of the market, over the forecast period. For instance, the article titled "Foreign animal disease concern: foot and mouth disease" published in December 2021 mentioned that Foot and mouth disease was a reportable disease in the United States. Foot and mouth disease devastates the United States livestock industry and causes catastrophic losses, hitting both the economy and animal welfare. Such impact on animal welfare by foot and mouth disease is expected to drive the demand for effective vaccination.
Also, the increasing product developments by various market players are expected to drive the growth of the market in this region. For instance, in August 2020 Zoetis, Inc applied for a petition to the Animal and Plant Health Inspection Services to approve the manufacture of foot and mouth disease vaccine in the United States.
Thus the above-mentioned factors are expected to drive the growth of the market in this region during the forecast period.
Foot & Mouth Disease Vaccines Industry Overview
The foot and mouth disease vaccines market are moderately fragmented in nature due to the presence of a few companies operating globally as well as regionally. The global players in the foot and mouth disease vaccines market are - Biogénesis Bagó, Boehringer Ingelheim GmbH, Brilliant Bio Pharma Pvt Ltd, China Animal Husbandry Group, Indian Immunologicals Limited, Limor de Colombia, Merck & Co. Inc., VECOL S.A and VETAL Animal Health Products.
Foot & Mouth Disease Vaccines Market Leaders
-
Biogénesis Bagó
-
Boehringer Ingelheim GmbH
-
Merck
-
VECOL S.A
-
VETAL Animal Health Products
*Disclaimer: Major Players sorted in no particular order
Foot & Mouth Disease Vaccines Market News
- In August 2022, the Nagaland government in India launched the second phase of the National Animal Disease Control Programme on foot and mouth disease (NADCP).
- In June 2022, the Indonesian government launched a livestock vaccination program as the number of cattle infected with foot and mouth disease surged to more than 151,000.
Foot & Mouth Disease Vaccines Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Incidences of Zoonotic Diseases
- 4.2.2 Increasing Demand for Animal Product
- 4.2.3 Rising R&D Activities in Animal Healthcare
-
4.3 Market Restraints
- 4.3.1 High Storage Costs for Vaccines
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Conventional Vaccines
- 5.1.2 Emergency Vaccines
-
5.2 By Animal Type
- 5.2.1 Cattle
- 5.2.2 Sheep and goat
- 5.2.3 Pig
- 5.2.4 Others
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Biogenesis Bago
- 6.1.2 Boehringer Ingelheim GmbH
- 6.1.3 Brilliant Bio Pharma Pvt Ltd
- 6.1.4 China Animal Husbandry Group
- 6.1.5 Indian Immunologicals Limited
- 6.1.6 Limor de Colombia
- 6.1.7 Merck & Co. Inc.
- 6.1.8 VECOL S.A
- 6.1.9 VETAL Animal Health Products
- 6.1.10 Biovet
- 6.1.11 Ceva Sante Animale
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityFoot & Mouth Disease Vaccines Industry Segmentation
As per the scope of the report, Foot and Mouth Disease (FMD) is an infectious disease, which majorly affects cattle, sheep, goats, and swine. FMD occurs in the animal population and poses a serious threat around the world. Foot and Mouth Disease is caused by an Apthovirus of the family Picornaviridae. The Foot and Mouth Disease Vaccine market is segmented by Product Type (Conventional Vaccines and Emergency Vaccines), Animal Type(Cattle, Sheep and Goat, Pig and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | Conventional Vaccines | |
| Emergency Vaccines | ||
| By Animal Type | Cattle | |
| Sheep and goat | ||
| Pig | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Foot & Mouth Disease Vaccines Market Research FAQs
What is the current Global Foot and Mouth Disease Vaccines Market size?
The Global Foot and Mouth Disease Vaccines Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)
Who are the key players in Global Foot and Mouth Disease Vaccines Market?
Biogénesis Bagó, Boehringer Ingelheim GmbH, Merck , VECOL S.A and VETAL Animal Health Products are the major companies operating in the Global Foot and Mouth Disease Vaccines Market.
Which is the fastest growing region in Global Foot and Mouth Disease Vaccines Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Foot and Mouth Disease Vaccines Market?
In 2024, the North America accounts for the largest market share in Global Foot and Mouth Disease Vaccines Market.
What years does this Global Foot and Mouth Disease Vaccines Market cover?
The report covers the Global Foot and Mouth Disease Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Foot and Mouth Disease Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Foot and Mouth Disease Vaccines Industry Report
Statistics for the 2024 Global Foot and Mouth Disease Vaccines market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Foot and Mouth Disease Vaccines analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
